94.985 6.155 (6.93%) | 04-23 12:45 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 140.28 | 1-year : | 168.42 |
Resists | First : | 120.1 | Second : | 144.19 |
Pivot price | 103.06 | |||
Supports | First : | 81.12 | Second : | 67.49 |
MAs | MA(5) : | 89.87 | MA(20) : | 108.9 |
MA(100) : | 119.75 | MA(250) : | 108.21 | |
MACD | MACD : | -11.1 | Signal : | -9.6 |
%K %D | K(14,3) : | 20.5 | D(3) : | 11.3 |
RSI | RSI(14): 36.9 | |||
52-week | High : | 176.99 | Low : | 48.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ LABU ] has closed above bottom band by 30.8%. Bollinger Bands are 16.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 92.24 - 92.86 | 92.86 - 93.41 |
Low: | 83.45 - 84.19 | 84.19 - 84.86 |
Close: | 87.66 - 88.85 | 88.85 - 89.93 |
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Wed, 03 Apr 2024
8 Best Leveraged ETFs of April 2024 – Forbes Advisor - Forbes
Fri, 03 Nov 2023
Direxion Announces Reverse Splits of TMF and LABU - Yahoo Finance
Wed, 01 Nov 2023
Get in Early on China's Economic Recovery With This ETF - ETF Trends
Thu, 05 Oct 2023
Retail Investors Dive Into Bond Market Wave: Treasury ETFs Attract Interest Amid Stock-Like Volatility - - Benzinga
Fri, 29 Sep 2023
Buy the Dip in Apple, or has the Trend Turned Rotten? - Investor's Business Daily
Mon, 03 Jul 2023
GUSH: More Than Double The Pain (NYSEARCA:GUSH) - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
AMEX
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |